Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee hands down positive opinion for Varuby

Feb. 27, 2017

EMA committee recommends broadening approval of Darzalex

Feb. 27, 2017

Tafinlar plus Mekinist granted positive opinion in E.U. for BRAF-positive NSCLC

Feb. 27, 2017

EMA CHMP gives positive opinion on ZS-9 for hyperkalemia

Feb. 27, 2017

EMA committee supports conditional marketing approval for Shire's Natpar

Feb. 27, 2017

EMA grants orphan drug designation to LYS-GM101 for the treatment of GM1 gangliosidosis

Feb. 22, 2017

Armetheon receives advice from EMA on pivotal study of oral anticoagulant

Feb. 15, 2017

EMA grants BioMarin's BMN-270 for hemophilia A access to PRIME initiative

Feb. 2, 2017

EMA accepts peramivir MAA from BioCryst

Jan. 31, 2017

Amgen receives positive opinion for biosimilar adalimumab ABP-501

Jan. 30, 2017

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...